Using micro-dosing technology and powder-in-capsule (PIC) or powder-in-bottle (PIB) approaches, biopharmaceutical companies can increase speed to clinic, quickly assess their candidate compounds, and remain cost-conscious in early stage development. In this webinar, Lonza experts review best practices PIC and PIB challenges and discuss rapid encapsulation transfer from clinic to commercial scale. To learn more, please view our on-demand webinar.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center